/term/short-ratio/XKLS:03006 Nova Pharma Solutions Bhd (XKLS:03006) Short Ratio
GURUFOCUS.COM » STOCK LIST » Industrials » Construction » Nova Pharma Solutions Bhd (XKLS:03006) » Definitions » Short Ratio

Nova Pharma Solutions Bhd (XKLS:03006) Short Ratio


View and export this data going back to 2018. Start your Free Trial

What is Nova Pharma Solutions Bhd Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Nova Pharma Solutions Bhd (XKLS:03006) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Industrials » Construction » Nova Pharma Solutions Bhd (XKLS:03006) » Definitions » Short Ratio
Comparable Companies
NSE:UNIINFO ASX:STN BOM:541006 NSE:HINDCON BOM:541083 MIL:KIP LSE:STRL TSXV:PEMC OSTO:ZUTEC XPAR:MLMIB OSL:SUNSB-ME ASX:EM2 NSE:SMSARVESHWAR HKSE:08168 HKSE:02182 HKSE:01737 HKSE:02363 LSE:SHH TSE:6570 BOM:541053
Traded in Other Exchanges
N/A
Address
Jalan USJ 25/1, Level 5, Suite C-5-1 & 2, Block C, Sky Park, One City, Subang Jaya, SGR, MYS, 47650
Website
http://www.novapharmasolutions.com
Nova Pharma Solutions Bhd provides engineering solutions to pharma and biotech industries. The company's reportable segments include Design fee, Post Design, & Other support fees. Design fee comprises conceptual designs which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipment and processes. Post design fee comprise tendering and procurement support as well as the construction of a plant, & Other support fees comprise of services to assist a customer in the good manufacturing practice document review & gap analysis and assessment. It generates a majority of its revenue from the Design fee segment. Geographically, the company generates a majority of its revenue from Malaysia.

Nova Pharma Solutions Bhd (XKLS:03006) Headlines

No Headlines